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Abstract
It is now generally recognised that different modes of programmed cell death (PCD) are intimately linked to the cancerous
process. However, the mechanism of PCD involved in cancer chemoprevention is much less clear and may be different
between types of chemopreventive agents and tumour cell types involved. Therefore, from a pharmacological view, it is
crucial during the earlier steps of drug development to define the cellular specificity of the candidate as well as its capacity
to bypass dysfunctional tumoral signalling pathways providing insensitivity to death stimuli. Studying the cytotoxic effects
of violacein, an antibiotic dihydro-indolone synthesised by an Amazon river Chromobacterium, we observed that death
induced in CD34+/c-Kit+/P-glycoprotein+/MRP1+ TF1 leukaemia progenitor cells is not mediated by apoptosis and/or
autophagy, since biomarkers of both types of cell death were not significantly affected by this compound. To clarify the
working mechanism of violacein, we performed kinome profiling using peptide arrays to yield comprehensive descriptions
of cellular kinase activities. Pro-death activity of violacein is actually carried out by inhibition of calpain and DAPK1 and
activation of PKA, AKT and PDK, followed by structural changes caused by endoplasmic reticulum stress and Golgi
apparatus collapse, leading to cellular demise. Our results demonstrate that violacein induces kinome reprogramming,
overcoming death signaling dysfunctions of intrinsically resistant human leukaemia cells.
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Introduction
The physiology of metazoan organisms requires mechanisms
that direct cellular death in a controlled fashion, a process
collectively denominated as programmed cell death (PCD) [1].
During embryology and further development to sexual maturity,
various structures like the pro-nephros and mesonephros have only
transient functionality and are orderly disposed off when no longer
necessary. Analogously, development of the immune system as
well as termination of ongoing host-defence responses require the
controlled elimination of a large number of effector cells [2].
Furthermore, aberrant compartment size regulation is implicated
in many serious pathologies (most dramatically, maybe, in cancer),
and prominently involves defects in PCD [3].
Cell-intrinsic programmed suicide has been functionally classi-
fied by the Committee on Cell Death 2012 as consisting of, so far,
13 separate molecular modes of cell death: Anoikis, autophagic
cell death, caspase-dependent intrinsic apoptosis, caspase-inde-
pendent intrinsic apoptosis, cornification, entosis, extrinsic apop-
tosis by death receptors, extrinsic apoptosis by dependence
receptors, mitotic catastrophe, necroptosis, netosis, parthanatos
and pyroptosis which are distinguished based on biochemical
features which are nicely reviewed in [4] and by the Committee on
Cell Death 2012 [4,5].
It is now generally recognised that different modes of PCD are
intimately linked to the cancerous process, as apoptotic cell death
is an important anti-neoplastic protective mechanism upon
improper induction of cellular proliferation, and is also involved
in cancer cell clearance by immunosurveillance, chemotherapy or
radiotherapy [6]. Autophagy, which counteracts other forms of
PCD including apoptosis, may play a role in the escape from
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chemotherapy by transformed cells [7]. Necroptosis and pyrop-
tosis are important for inducing cell death during inflammatory
reactions, thereby preventing inflammation-associated cancer [4].
In addition, chemoprevention of cancer is also thought to be
linked to PCD, inducing cellular suicide in pre-neoplastic lesions
and thus halting development of full-blown cancer [8]. The mode
of PCD involved in cancer chemoprevention is much less clear and
may be different between types of chemopreventive agents and
tumour cell types involved. Chemoprevention of colorectal cancer
by NSAIDS, for instance, is most often linked to a pro-apoptotic
response in the transformed compartment [9], but the robust
chemoprevention of the same cancer type by the use of statins is
linked to necroptosis [10]. Moreover, we have recently presented
evidence that chemoprevention induced by apigenin is linked to an
autophagic response [7]. Generally speaking however the mode of
PCD by many important cancer chemopreventive agents remains
poorly characterised, prompting further research in this area.
One such chemopreventive compound is Violacein [3-(1,2-
dihydro-5-(5-hydroxy-1H-indol-3-yl)-2-oxo-3H-pyrrol-3-ilydene)-
1,3-dihydro-2H-indol-2-one], a purple-colored pigment produced
by Chromobacterium violaceum, a bacterium present in certain parts of
the Amazon river basin in Brazil [11]. Violacein shares an
interesting antitumor activity with various other naturally occur-
ring indolones [12]. Violacein has previously been shown to
induce apoptosis of HL60 leukaemia cells. Interestingly, TF1 cells
which are less differentiated than HL60 seems to be more resistant
to violacein-induced apoptosis [13]. However, violacein is still able
to induce death in these cells via an alternative mechanism.
In an effort to obtain further insight into the molecular
mechanisms of violacein-mediated anti-proliferative responses,
we studied the effect of this compound on TF1 leukaemia cells. We
observed induction of cellular suicide in these leukaemia cells, and
subsequent morphological investigation revealed a mode of cell
death involving endoplasmic reticulum and Golgi linearization
and ‘horseshoe-shaped’ nucleus. To investigate the mechanism of
violacein-induced death in TF1 cells, we performed kinome
profiling using peptide arrays to yield comprehensive descriptions
of cellular kinase activities. Kinome profiling revealed a calpain
based mechanism leading to cellular demise. Thus, our findings
demonstrate that this non-canonic mechanism of cell death
induced by violacein might explain its strong antileukaemic
properties even in cell lines which are less sensitive to classical
induction of cell death.
Materials and Methods
Reagents
Polyclonal antibodies against ERK1/2 (Thr202/Tyr204),
MAPAPK2 (Thr222), p38 (Thr180/Tyr182), mTOR (Ser2448),
PKB, phospho-PDK1 (Ser241), phospho-GSK3b (Ser9), LC3B
and Beclin1, were purchased from Cell Signaling Technology
(Beverly, MA). Secondary anti-rabbit and anti-mouse peroxidase-
conjugated antibodies were also obtained from Cell Signaling
Technology (Beverly, MA). Antibodies against anti-MAP LC3 and
cleaved-PARP and secondary anti-goat antibodies were purchased
from Santa Cruz (St. Louis, MO). Anti-Fas receptor (Fas) and anti-
Fas ligand (FasL) were from Immunotech (Marseille, France).
TNFa was obtained from R&D Systems. Violacein (3-(1,2-
dihydro-5-(5-hydroxy-1H-indol-3-yl)-2-oxo-3H-pyrrol-3-ilydene)-
1,3-dihydro-2H-indol-2-one) was extracted and purified as previ-
ously described [14].
Cell culture and Treatments
TF1 cell line was purchased from American Type Culture
Collection (ATCC, Rockville, MD). Cells were routinely grown in
RPMI 1640 culture medium (Gibco) containing 10% fetal bovine
serum, 2 mM L-glutamine, 5 ng/ml GM-CSF, 100 units/mL
penicillin and 100 mg/mL streptomycin at 37uC in a humidified
incubator with 5% CO2 in air.
Cell viability
Cell viability was assessed by trypan blue dye exclusion and
MTT reduction assays as previously reported [10,15].
Cell Cycle Analysis
TF1 cells were cultured for 24 hours at a density of 26104 cells/
ml in serum free RPMI. After 24 h of serum starvation cells were
treated with violacein for 24 h, and subsequently cells were
washed with PBS and resuspended in 200 ml of a sodium citrate
dihydrate (1 g/L) solution, containing 50 ml Ribonuclease A
(10 mg/ml; Fermentas), propidium iodide 0.02 mg/ml (Sigma)
and Triton X-100 (Sigma) 0.1%. Next, the cells were incubated in
the dark for 60 min at room temperature. The analysis was
performed in a FACSCalibur flow cytometer (BD Biosciences, San
Jose, CA, USA). The cells were analyzed in low speed and at least
10,000 events were analyzed per sample. The DNA content was
evaluated using a FL2 detector in a linear scale. To eliminate cell
aggregates, the cell population to be analyzed was selected from a
bivariate histogram showing the area (FL2A) versus the width
(FL2W) of the signal FL2. The analysis of cell percentage in the
different phases of the cell cycle (G0/G1, S, and G2/M) was
performed using the ModFit LT software (BD Biosciences, San
Jose, CA, USA).
Western blotting
Cells (36107) were lysed in 200 mL cell lysis buffer (50 mM Tris
[tris(hydroxymethyl)aminomethane]–HCl [pH 7.4], 1% Tween
20, 0.25% sodium deoxycholate, 150 mM NaCl, 1 mM EGTA
(ethylene glycol tetraacetic acid), 1 mM O-Vanadate, 1 mM NaF,
and protease inhibitors [1 mg/mL aprotinin, 10 mg/mL leupeptin,
and 1 mM 4-(2-amino-ethyl)-benzolsulfonyl-fluoride-hydrochlo-
ride]) for 2 h on ice. Protein extracts were cleared by centrifuga-
tion, and the protein concentration was determined using Lowry.
An equal volume of 26 sodium dodecyl sulfide (SDS) gel loading
buffer (100 mM Tris-HCl [pH 6.8], 200 mM dithiothreitol
[DTT], 4% SDS, 0.1% bromophenol blue and 20% glycerol)
was added and the samples were boiled for 10 minutes. Cell
extracts, corresponding to 36105 cells, were resolved by SDS-
polyacrylamide gel (12%) electrophoresis (PAGE) and transferred
to polyvinylidene difluoride (PVDF) membranes. Membranes were
blocked in 1% fat-free dried milk or bovine serum albumin (2%) in
Tris-buffered saline (TBS)–Tween 20 (0.05%) and incubated
overnight at 4uC with appropriate primary antibody at 1:1000
dilution. After washing in TBS-Tween 20 (0.05%), membranes
were incubated with anti-rabbit, anti-goat and anti-mouse
horseradish peroxidase-conjugated secondary antibodies at
1:2000 dilutions (in all Western blotting assays) in blocking buffer
for 1 h. Detection was performed by using enhanced chemilumi-
nescence (ECL).
Transmission electron microscopy
After incubated with violacein, the cells were fixed with 2.0%
phosphate-buffered glutaraldehyde. The cells were then postfixed
in 1% phosphate-buffered OsO4, and embedded in Spurr’s resin.
Thin sections (0.12 mm) were cut, double stained with UO2(CH3-
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COO)2 (uranyl acetate) and Pb3C12H10O14 (lead citrate), and
visualized with a Philips TECNA10 transmission electron micro-
scope (TEM). Fifty cells from randomly chosen TEM fields were
analyzed for each treatment or control [16].
Kinomic array
Kinome arrays were performed essentially as described before.
[17–19]. In short, cells were washed in PBS and lysed in a non-
denaturing complete lysis buffer. The peptide arrays (Pepscan,
Lelystad, The Netherlands), containing up to 1024 different kinase
substrates in triplicate, were incubated with the cell lysates for 2 h
in a humidified incubator at 37uC. Subsequently, the arrays were
washed in 2 M NaCl, 1% Triton-X-100, PBS, 0.1% Tween and
water; thereafter slides were exposed to a phospho-imaging screen
for 24–72 h and scanned on a phospho-imager (Fuji, Stanford,
USA). The level of incorporated radioactivity, which reflects the
extent of phosphorylation, was quantified with specific array
software (EisenLab ScanAlyze, version 2.50). Datasets from chips
were then analyzed statistically using PepMatrix, as described by
Milani et al. 2010. Basically, spot replications were scrutinized for
consistency using two indexes: one being the standard deviatio-
n:average (SD/A) ratio and the other being the ratio between the
average and the median (A/M) of all three replications for each
chip. Parameters applied to the indexes were an SD/A,50% and
80%,A/M,120%. The fold change in phosphorylation between
control and treated cells was assessed using Student’s t-test, with
P,0.05 indicating significance. Distribution of shared events in
TF1 cells in response to violacein treatment was visualized using
Venny (Oliveros, J.C. (2007) VENNY http://bioinfogp.cnb.csic.
es/tools/venny/index.html) and heat map was constructed in R
2.12.0 (R Foundation for Statistical Computing, Vienna, Austria)
using heatmap.2.
Statistical evaluation
The Western blots represent 3 independent experiments. Cell
viability data were expressed as the means 6 standard deviation of
3 independent experiments carried out in triplicates. Data from
each assay were analyzed statistically by ANOVA. Multiple
comparisons among group mean differences were checked with
the Tukey test. Differences were considered significant when the p
value was less than 0.05.
Results
Violacein displays antiproliferative action on TF1
leukaemia cells
CD34+/c-Kit+/P-glycoprotein+/MRP1+ TF1 leukaemia pro-
genitor cells have been reported to be unusually resistant against
PCD [20]. In apparent agreement, we observed that neither
stimulation with high concentrations of Fas ligand, tumour
necrosis factor (TNF)a or strong chemotherapeutic agents like
mitoxatrone for 24 hours affected TF1 survival to a large degree as
assessed by MTT reduction (figure 1a). Importantly, however,
these cells turned out to be sensitive to violacein, with clear effects
on MTT reduction already being evident in the low mM range
after 24 h and 2 mM violacein was incompatible with TF1 cell
survival after 72 h (figure 1b). Subsequent analysis showed that
the cell death by violacein is not accompanied by loss of trypan
blue exclusion or relevant numbers of annexin V/PI-positive cells
(control 9.5%60.76 and Violacein 2 mM 15.6%60.5) (not shown);
suggesting that the effect of violacein is not due to direct toxic
necrosis or classical apoptosis but to a specific cell death
programme. In addition, analysis of TF1 cell DNA content shows
that violacein-dependent cell death was accompanied by destruc-
tion of the genome (figure 1c). Previously, we have shown that
violacein induces apoptosis of HL60 leukaemia [23]. However,
due to the fact that TF1 cells are quite resistant to traditional cell
death inductors, such as mitoxantrone and TNFa and violacein
managed to overcome this phenotype, we next examined the
molecular mechanism by which violacein promotes TF1 cell
death.
Violacein does not induce cellular suicide through the
canonical PCD modes
PCD can progress through different types of molecular system
which will ultimately cause cell death [4]. However, a dominant
PCD mechanism was not observed in TF1 cells treated with
violacein. Caspase-dependent apoptosis is excluded since inhibi-
tors of pro-apoptotic caspases did not affect violacein-dependent
cell death (figure 2a). Also, the known class III PI3K inhibitor, 3-
methyladenine (3-MA, 5 mM), which inhibits the formation of
autophagosomes [21], has no effect on violacein-induced cell
death (figure 2b). Furthermore, the apparent absence of a
necrotic effect of violacein, as assayed by the ethidium bromide/
acridine orange assay (figure 2c), is at bay with a major role for
violacein on TF1 cell survival. Thus, death of TF1 cells following
application of violacein seems not to be mediated by one of the
canonical PCD modalities. In apparent agreement, violacein
induced neither increased expression of Beclin-1 nor massive
formation of the autophagosome associated form of LC3-B
(figure 2d), further excluding an important role of autophagic
cell death in violacein-mediated cell death. Nevertheless, violacein
treatment slightly increased the levels of cleaved PARP
(figure 2d).
Ultrastructural characterisation of violacein effects in TF1
cells reveals endoplasmic reticulum and Golgi
linearization
To obtain further insight into the mechanisms underlying TF1
cell death following violacein treatment, the ultrastructure of these
cells was studied using transmission electron microscopy
(figure 3a). Plasma membrane integrity was maintained until
almost the final stages of cellular suicide and no increase in the
number of autophagosomes was observed. In addition, no
apparent morphological evidence for induction of autophagic cell
death (as the vesicles observed do not present double membranes
which is characteristic of this type of cell death), apoptosis or
necroptosis was observed. However, violacein-induced cell death
was followed by endoplasmic reticulum and Golgi linearization
(see high power magnification pictures in figure 3b), and ,at later
time frame, the appearance of ‘horseshoe-shaped’ nuclei, initiating
the last phase before cellular demise, becomes prominent.
Violacein caused a dynamic reprogramming in TF1 cells
kinases assessed by Western Blot
Due to the strong inhibitory effect of violacein on the TF1 cell
proliferation rate, the modulation status of some kinases was
examined by western blot. PDK and AKT presented higher
phosphorylation levels at positive regulatory sites, which indicated
that violacein promotes activation of both enzymes. Src kinase was
less active, since the inhibitory site at tyrosine residue 527 was
phosphorylated. Activation of AKT, an important pro-survival
kinase, could explain the absence of a strong effect of violacein on
apoptotic and autophagic markers. On the other hand, the
negative modulation of Src kinase might be, at least in part,
responsible for the antiproliferative action of this compound
(figure 4a).
Kinome Reprogramming and Cell Death by Violacein
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mTOR kinase was not significantly affected by violacein. In
relation to GSK, MAPKAP2, p38 and p42/44 kinases, we
observed a transient influence of violacein along the evaluated
time frame (figure 4a). These results indicate that the violacein-
induced cell death is potentially triggered by oxidative stress as
MAP kinases in these circumstances present themselves as pro-cell
death signals [22]. Indeed, this is in line with the structures
observed by EM in which we clearly observed ER and Golgi
linearization probably caused by violacein-induced stress. Also, the
strong activation of death associated protein kinase, which has
been associated with PCD related to interferon-c withdrawal but is
also known to inhibit apoptosis and whose role in PCD thus
remains obscure [23], is an obvious candidate mediator in
violacein action. Particularly considering that this kinase seems
to facilitate the interplay of different cell death subroutines [24]. In
addition, the calpain L1 large subunit is significantly less
phosphorylated in violacein-treated cells, an event associated with
deactivation of this cysteine protease [25]. Importantly, defects in
calpain functionality are associated with a variety of deficiencies,
including lethality, dystrophy, and tumorigenesis, suggesting that a
calpain-like system could be important to induce programmed cell
death in these cells [26]. Hence, we investigated the capacity of
calpeptin (an inhibitor of calpain enzymatic activity [27]) to mimic
violacein effects on cell death and indeed we observed that such
inhibition is almost equipotent to violacein in inducing cell death
in TF1 cells (figure 4b), indicating that the calpain system also
may play a role in PCD induced by violacein.
Violacein caused a dynamic reprogramming in TF1 cells
kinases assessed by Kinome Profiling
Absence of a priori assumptions of the biochemical mechanisms
that mediate the morphological effects of PCD induced by
violacein prompted us to look for techniques that allow the
generation of unbiased and comprehensive descriptions of cellular
signalling. One such technique is kinome profiling using peptide
arrays. We have used this methodology successfully to unravel the
signalling mechanisms mediating, amongst others, chemopreven-
tion by coxibs in colorectal cancer [28] or the non-genomic
mechanisms employed by the glucocorticoid receptor [29] to limit
white blood compartment expansion. For the present study, we
generated kinome profiles using peptide arrays by incubating TF1
cell lysates obtained from cultures either untreated or subjected to
2 mM Violacein treatments for respectively 30 min, 16 h and
24 h. The arrays incorporated substantial amounts of radioactivity
and the technical quality of the profiles was good as the average
Pearson product moment obtained for the technical replicas
ranged from 0.78 to 0.90 (Table S1). Application of violacein to
cells caused an important and dynamic kinome reprogramming,
which progresses over time (figure 4c). This is perhaps better
visualized in figure 4d which shows a heat map built from the
significantly altered kinases in TF1 cells lysates in response to
violacein. Violacein-treated cells present a remarkably different
profile in later time points (16 and 24 hrs) which are more alike
compared to control or violacein treatment for 30 min (figure 4d).
In figure 4e a Venn diagram depicting the distribution of up and
Figure 1. Induction of cell death by violacein in intrinsically resistant TF1 myeloerythroid leukaemia cells. (A) TF1 cells are unusually
resistant with respect to PCD. Cells were exposed for 24 hrs to FasL, TNFa and mitoxantrone. (B) TF1 cells were exposed to various concentrations of
violacein (X-axis) in the presence of 10% FCS and analysed for cellular survival (as assayed by the capacity of cellular cultures to reduce MTT; Y-axis)
24 hrs, 48 hrs and 72 hrs later as indicated. (C) Analysis of cellular DNA content by FACS shows that violacein-induced TF cell death is accompanied
by breakdown of the genome. Each value represents the mean 6 SEM of three independent experiments.
doi:10.1371/journal.pone.0045362.g001
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downregulated kinases at different time points is shown. Densito-
metric values for all substrates and the statistical significance of the
results obtained compared to untreated cells for all time points are
given in Table S2. In figure 4f graphs presenting a correlation
between fold change and p-value for each time point compared to
control are presented. Analysis of these profiles, however, produces
little evidence for an involvement of canonical PCD pathways in
violacein-induced effects in TF1 cells. As it is also shown in
figure 4f, the PKB/mTOR pathway, whose activation is
associated with inhibition of both apoptotic and autophagic
PCD modalities [30], is not significantly affected by violacein
treatment.
Kinome profiling brought out some kinases which are
differently modulated along the treatment of TF1 cells with
violacein. Importantly, in agreement with viability and cell cycle
analysis, some kinases that favour cell cycle progression and cell
survival, such as CDK, Rock, Axl and AurkA, were negatively
modulated by violacein, after 16 and 24 h. On the other hand, a
huge set of kinases appeared more active in treated TF1 cells.
Among those, some have not been reported as mediators of cell
death or reticulum stress. Importantly, violacein modulated two
kinases that have been linked with reticulum stress and cell death
via apoptosis and autophagy. Violacein caused an expressive
activation of PKA, as observed by the higher phosphorylation level
of its substrate CREB1 observed on the peptide chip. In addition,
we detected an increase of autophosphorylation of DAPK1 at its
inhibitory site by violacein treatment.
Discussion
Violacein and related indolic compounds attract attention
because of their presumed chemopreventive action, originally
discovered from epidemiological studies in the Amazon basin [31].
Although clearly highly biologically active [13,32], the mechanism
by which violacein might interfere with tumor cells remains
partially unclear. Nevertheless, it has become evident that despite
the absence of induction of cell death in untransformed cells or low
in vivo toxicity of the compound in humans and experimental
animals [32–33], it is strongly cytotoxic towards a number of
transformed cell types. Specifically in relation to leukaemia, we
have shown earlier that this pigment induces apoptosis of human
chronic myeloid leukaemia cells (HL60) by intrinsic and extrinsic
pathways. In order to provide more information about the
potential antileukemic action of violacein, in the present study we
examined the effect of violacein on a chemoresistant CD34+/c-
Kit+/P-glycoprotein+/MRP1+ TF1 leukaemia progenitor cell line.
Our findings revealed that violacein was able to bypass the natural
resistance of TF1 cells, mainly through activating kinases that
promote reticulum stress. Interestingly, some kinases that are
involved in cell death via apoptosis and autophagy were inhibited
after violacein treatment. The induction of PARP cleavage and the
resulting breakdown of the cellular genome as well as the absence
of trypan blue incorporation during violacein-induced cell death
indicate that violacein acts through a specific cellular suicide
program. All currently described forms of cell death seem to a
Figure 2. Induction of cell death by violacein does not progress through canonical modes of programmed cell death. (A) Cell death
induced in TF1 cells by a 24 hrs treatment with 2 mM of violacein is not sensitive to inhibitors of pro-apoptotic caspases. (B) The autophagosome
inhibitor 3-methyladenine does not impair violacein-induced cellular suicide in TF1 cells. (C) Apparent absence of a necrotic effect of violacein in TF1
cells, as assayed by the ethidium bromide/acridine orange assay. (D) Western blot analysis of beclin-1 and autophagy-specific LC3B isoform levels
excludes a major role of autophagy in violacein effects in TF1 cells. Nevertheless, violacein clearly increases levels of cleaved PARP and thus cell death
induction by violacein represents a mode of PCD.
doi:10.1371/journal.pone.0045362.g002
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certain extent to be inhibitory to other forms of PCD [4] and the
form induced by violacein does not appear to be an exception.
Studies of cellular biochemistry, ultrastructural morphology and
inhibitors of apoptosis, autophagy and pyroptosis indicate that
violacein acts through a molecular mechanism distinct from these
known manifestations of cellular death. In apparent agreement,
detailed ultrastructural characterisation of violacein effects on
cellular morphology revealed a unique cascade of events involving
first endoplasmic reticulum and Golgi linearization and at later
time points the nuclei assume a ‘horseshoe shape’. Biochemically,
these morphological events were accompanied by highly distinc-
tive effects on the kinome and concomitant downregulation of the
Calpain cysteine protease system. Despite kinome profiling
allowed us to elect a set of kinases that was differentially affected
by violacein, in this section we will point out those that gave us
support to explain the fate of TF1 cells towards this pigment.
Violacein effects are accompanied by strong activation of
survival and anti-autophagic/anti-apoptotic signalling pathways
through the AKT and PDK activation and inhibition of DAPK1,
which counteracts both apoptosis as well as autophagic cell death.
Activation of AKT signalling induced by violacein might be due to
reticulum stress, as it has been previously reported that AKT driven
signalling is enhanced under reticulum stress. Some reports pointed out
that endoplasmic reticulum and Golgi apparatus can positively
modulate both pro-survival (mainly related to protection responses)
mechanisms as well as cell suicide when the stress stimuli threshold is
exceeded [34]. DAPK1 has been reported to be an important mediator
of apoptosis and autophagy [35,36] and, since it was observed that
violacein caused an expressive inhibition of this kinase, this fact can
explain, at least in part, the absence of identification of typical markers
of apoptosis or autophagy in TF1 cells treated with violacein.
The exact biochemical details by which violacein-induced cell
death progresses evidently require further analysis, but it is
interesting to see that inhibition of calpain mimics important
aspects of the effect observed in response to violacein, suggesting
that inhibition of calpain enzymatic activity may be an important
factor in this process. In apparent agreement, genetic ablation of
calpain enzymatic activity strongly decreases the propensity to
tumorigenesis in experimental animals [37].
In general, the data presented here provide basis to explain the
broad action of violacein as antitumoral agent. It is important to
emphasize that violacein was able to induce death of resistant
leukaemia cells, and kinome determination was a valuable strategy
to select crucial kinases for this mechanism.
Supporting Information
Table S1 Technical quality of kinome profiling. Cells were lysed
and incubated on peptide arrays (1024 spots from which represent
974 bona fide kinase consensus substrates and 50 technical
controls) in the presence of 33P-c-ATP. Subsequently for each
substrate phosphorylation was determined using a phosphoimager,
yielding a dataset. Three datasets of each condition were obtained
by parallel incubation of peptide array, yielding dataset 1 through
3 for each condition (technical replicates). The results depicted in
the table represent the Pearson moment between these technical
replicates and was always in excess of 0.78.
(DOC)
Table S2 Results of kinome profiling of TF1 cells exposed for
30 min, 16 hrs or 24 hrs to 2 mM violacein compared to control.
Following violacein incubation, cells were lysed and incubated on
peptide arrays (1024 spots from which represent 974 bona fide
kinase consensus substrates and 50 technical controls) in the
presence of 33P-c-ATP. Subsequently for each substrate phos-
phorylation was determined using a phosphoimager, yielding a
dataset. Tables show peptide motifs employed by the correspond-
ing source protein from which the peptide motif was obtained, the
average phosphorylation obtained from three datasets and its
standard deviation. For those peptides of which the phosphory-
lation following violacein treatment was statistically significant
different from control cultures, the P value is given as well.
(XLS)
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Figure 3. Induction of cell death by violacein is associated with
an ultrastructurally unique programme of cellular demise. (A)
Using transmission electron microscopy, the ultrastructural effects of
violacein-induced cell death were characterised at different time points
following application of the indole derivative. No apparent morpho-
logical evidence for induction of either autophagy, apoptosis,
necroptosis or pyroptosis is obtained, as for instance the integrity of
the mitochondria and plasma membrane is maintained until the final
stages of cellular suicide and no increase in the number of
autophagosomes is seen. Highly distinctive of violacein-induced cell
death, however, is the endoplasmic reticulum and Golgi linearization
and at later time points nuclear mottening. (B) High magnification
examples of endoplasmic reticulum and Golgi linearization, character-
istic for violacein effects 20 hrs following application of the chemopre-
ventive indole.
doi:10.1371/journal.pone.0045362.g003
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Figure 4. Induction of cell death by violacein is associated with a major rearrangement of cellular biochemistry. (A) The PKB-mediated
survival cassette is not inhibited by 2 mM violacein treatment in TF1 cells. Although Western Blot analysis of signalling intermediate phosphorylation
does not perfectly correlate with the kinase enzymatic activity, it is obvious that also phosphorylation status analysis does not provide evidence for
diminished survival signalling following TF1 cell stimulation. Note that GSK3b activity is negatively regulated by its PKB-mediated phosphorylation (B)
Viability of TF1 cells was evaluated in the presence of Calpeptin (50 mM) or after violacein (2 mM) treatment. (C) Plotting correlation between
phosphorylation of specific peptide substrates shows that 30 minutes following violacein treatment only minor changes in the cellular kinome are
observed. More long-term treatment, however, causes major remodelling of the kinome. The value in the graph gives the Pearson product. (D)
Heatmap of significantly altered kinases in TF1 cells in response to violacein treatment. (E) Venn diagram depicting the distribution of phosphorylated
spots at different time points (30 min is depicted in blue, 16 hrs in yellow and 24 hrs in green). (F) Comparison between statistically significant
phosphorylated spots in TF1 cells treated with 2 mM violacein for 0 hrs with cells treated for 16 hrs and 24 hrs. This graph shows the correlation
between fold change and p-values for the statistically significant phosphorylated spots at the different time points of treatment with violacein.
doi:10.1371/journal.pone.0045362.g004
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